At Skin Works Medical Spa in Torrance, peptide therapy begins with a medical consultation. From there, our team offers consultation-led programs for recovery, body composition, skin support, cognitive goals, longevity and sexual wellness. In addition, the medical team confirms the specific compound, formulation and pharmacy availability before treatment.
Prescription required. Many peptide uses are investigational or off-label. Availability can change with federal/state rules and pharmacy sourcing.
Our Black Friday offers apply to the complete treatment cycles listed below at Skin Works Torrance. If your provider approves a program, the Black Friday rate remains available for future prescribed cycles while your treatment plan stays active. You do not need to choose a peptide before your consultation.
Provider-directed rest periods preserve your rate. If you voluntarily stop or allow the program to lapse, the price available when you restart will apply.
Medical eligibility, prescription, current formulation and pharmacy availability are confirmed before treatment.
The clinic discusses programs for soft-tissue recovery, post-procedure support and related goals. However, these compounds are not FDA-approved for these wellness uses, and availability can change.
Back to categoriesThis clinic-defined compounded blend combines BPC-157 and a TB-500-related peptide for patients exploring recovery support. However, both components remain investigational for these uses and are not FDA-approved drugs.
Ask about this programBPC-157 is an investigational peptide frequently discussed in recovery settings. However, human evidence remains limited, and it is not FDA-approved. Before treatment, the medical team must confirm the form, prescription and availability.
Ask about this programTB-500-related peptides are investigational and not FDA-approved. For this reason, the clinic may discuss them for selected recovery goals only after reviewing candidacy, evidence, risks and current pharmacy availability.
Ask about this program
Options in this category act on or relate to growth-hormone signaling. However, candidacy, laboratory review, risks and regulatory status differ substantially by compound.
Back to categoriesThe clinic may discuss this compounded growth-hormone-axis combination for selected wellness goals. However, neither compound is FDA-approved for the broad anti-aging or body-composition claims commonly made online. The medical team should also confirm current compounding status.
Ask about this programTesamorelin is the active ingredient in Egrifta, an FDA-approved drug for reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. However, it is not FDA-approved as a general weight-loss drug. Therefore, any use outside the approved indication requires separate medical judgment.
Ask about this programAOD-9604 is an investigational growth-hormone fragment marketed for body-composition goals. However, it is not FDA-approved, and evidence for routine weight-management use remains limited.
Ask about this programFor instance, some compounded protocols use sermorelin, a growth-hormone-releasing hormone analogue. In addition, the medical team reviews current formulation, clinical rationale and pharmacy availability for each patient before prescription.
Ask about this program
The clinic discusses peptide-based programs alongside aesthetic care. Importantly, formulation matters: injectable and topical/non-injectable products can have different regulatory considerations.
Back to categoriesThis clinic-defined blend combines GHK-Cu, BPC-157 and a TB-500-related peptide. Because the components have different evidence and regulatory profiles, the medical team confirms formulation and availability at consultation.
Ask about this programResearchers have studied GHK-Cu, a naturally occurring copper-binding peptide, in skin and wound biology. Because topical/non-injectable and injectable formulations have different regulatory considerations, the clinic confirms formulation availability.
Ask about this program
Semax and Selank are investigational in the United States and are not FDA-approved drugs. Therefore, any use requires individualized medical review and confirmation of legal pharmacy availability.
Back to categoriesResearchers have studied the investigational peptide Semax primarily outside the United States. However, it is not FDA-approved in the U.S., and claims around cognition and neuroprotection remain investigational.
Ask about this programSimilarly, researchers have studied the investigational peptide Selank primarily outside the United States. However, it is not FDA-approved in the U.S. For this reason, the clinic does not present it as a proven replacement for approved anxiety or mood treatments.
Ask about this programThis clinic-defined combination includes Semax and Selank. Because both are investigational in the United States, the medical team reviews evidence, candidacy and current pharmacy availability before any prescription.
Ask about this program
These programs include investigational compounds with evolving evidence and compounding status. Therefore, a medical consultation is necessary to review suitability, potential risks and current legal availability.
Back to categoriesThis clinic-defined blend combines GLOW70 with KPV. Because its components are investigational for these wellness uses, the medical team reviews candidacy, evidence, risks and current pharmacy availability before prescription.
Ask about this programResearchers continue to study MOTS-c, a mitochondrial-derived peptide. However, it is not FDA-approved for metabolic optimization, weight loss or longevity, and human clinical evidence remains limited.
Ask about this programFor example, longevity research includes the investigational peptide Epitalon (Epithalon). However, it is not FDA-approved in the United States, and claims involving telomeres or lifespan remain investigational.
Ask about this programIn addition, researchers have studied thymosin alpha-1 internationally for immune-related indications. However, it is not an FDA-approved drug in the United States. Therefore, its use and availability require individualized medical review.
Ask about this program
Although bremelanotide is the active ingredient in FDA-approved Vyleesi, that approval covers a specific indication. Other uses do not fall under the labeled Vyleesi indication.
Back to categoriesSpecifically, the FDA approved Vyleesi (bremelanotide) for acquired, generalized hypoactive sexual desire disorder in premenopausal women. However, Vyleesi is not FDA-approved for men, postmenopausal women, performance enhancement or general libido optimization. Any other use is outside the labeled indication.
Ask about this programPeptide therapy in Torrance begins with a medical evaluation, not a one-size-fits-all wellness menu. Peptides are short chains of amino acids involved in many signaling pathways in the body. However, not every marketed peptide has proven clinical benefit. For this reason, the key questions are which compound to consider, what evidence supports the goal, whether the formulation is legally available, and whether it makes sense for the individual.
First, the medical team reviews health history, medications, goals, contraindications and the evidence behind a proposed protocol before prescription.
Compounding rules and pharmacy availability can change. Therefore, treatment must comply with applicable federal and state requirements.
For example, FDA approval of a branded medication for a specific condition does not extend to compounded versions or other uses.
If your provider prescribes a protocol, the team also remains available for administration guidance, follow-up questions and appropriate reassessment.
Many peptides marketed in wellness settings are not FDA-approved drugs. In addition, a licensed pharmacy does not make a compounded medication FDA-approved simply by preparing it.
The programs and prices listed below remain subject to medical review. At consultation, the medical team confirms actual availability, formulation, pharmacy source and prescription; these details may change. Furthermore, FDA-approved tesamorelin and bremelanotide products have narrow labeled indications, so their approval does not extend to other uses.
During consultation, your provider considers your goals and makes a clinical decision, including whether peptide therapy should be used at all.
Discuss your goals, health history, medications and the specific program you are interested in.
Your medical provider determines candidacy, current legal/pharmacy availability and whether a prescription is appropriate.
If your provider prescribes a protocol, you receive administration guidance, an appropriate follow-up plan and the special cycle price shown for your selected program.
Peptide therapy should be discussed compound by compound rather than treated as one single category of medicine.
Peptide consultations are available at Skin Works Medical Spa, 2573 Pacific Coast Highway, Suite B, Torrance, CA 90505. The Torrance clinic also serves patients from Redondo Beach, Lomita, the Palos Verdes Peninsula, Carson, Gardena, San Pedro and surrounding South Bay communities.
Yes. In fact, prescription peptide programs at Skin Works require a medical evaluation and an appropriate prescription. During consultation, our team also confirms whether the requested compound is currently available through an appropriate pharmacy pathway.
No. In fact, many compounds on wellness peptide menus are investigational and are not FDA-approved drugs. Although tesamorelin and bremelanotide have FDA-approved branded products for specific indications, that approval does not automatically extend to compounded versions or different uses.
Not FDA-approved for ordinary belly-fat or general weight-loss treatment. Specifically, the FDA approved Egrifta to reduce excess abdominal fat in adults with HIV-associated lipodystrophy, not for general weight-loss management. Therefore, any other use requires separate medical judgment and must not be described as FDA-approved.
FDA approval does not extend to men. Instead, the FDA approved Vyleesi for acquired, generalized hypoactive sexual desire disorder in premenopausal women. In addition, its label states that Vyleesi is not indicated for men or postmenopausal women and is not a performance-enhancement drug. Other prescribing falls outside the labeled indication.
For example, compounding rules, FDA policy, state requirements and pharmacy sourcing can change. In addition, federal authorities are actively reviewing some peptide bulk substances. As a result, Skin Works confirms current availability before finalizing any prescription or payment.
That depends on the specific medication, formulation and provider decision. When home administration is appropriate, the clinic can also provide instruction and follow-up. Some products may use non-injectable formulations.
Begin an approved program at its Black Friday price and continue the prescribed plan. Provider-directed rest periods preserve the rate. If you voluntarily stop or allow the program to lapse, the price available when you restart will apply.
There is no universal peptide timeline. Instead, evidence and expected responses vary by compound and indication. Your provider should therefore set expectations for the specific medication rather than promise a generic two- or four-week result.
That is the purpose of the consultation. Begin with the outcome you care about rather than choosing a peptide from a list. Next, the medical team can explain which options have the strongest rationale, which are investigational, and whether another treatment may be more appropriate.
Meet our medical team at 2573 Pacific Coast Highway, Suite B in Torrance. We welcome patients from Redondo Beach, Lomita, Palos Verdes, Rolling Hills Estates, Carson, Gardena, San Pedro and surrounding South Bay communities.
Meet with the Skin Works medical team in Torrance, discuss your goals and receive a clear explanation of candidacy, current options, complete-cycle pricing and whether peptide therapy is appropriate for you.
Medical disclaimer: This page is informational and does not constitute medical advice or a prescription. In addition, program availability, formulation, price and pharmacy sourcing may change. In addition, many peptide compounds and wellness uses described on the market are not FDA-approved. Unlike FDA-approved drugs, compounded drugs do not undergo FDA premarketing review for safety, effectiveness or quality. Black Friday pricing requires medical approval and applies while the prescribed treatment plan remains active. Provider-directed rest periods do not interrupt rate protection. If a patient stops or allows the program to lapse, the price available at restart applies.